To assess the effects of postoperative radiation therapy and chemotherapy on tumor recurrence and patient survival, 227 patients (data on 202 of whom were analyzed) who had undergone "curative" surgical resection for rectal adenocarcinoma were prospectively and randomly assigned to one of four treatments: no adjuvant therapy (concurrent controls, 58 patients), postoperative radiotherapy with 4000 or 4800 rad (50 patients), postoperative chemotherapy (fluorouracil and semustine [methyl-CCNU], 48 patients), or a combination of radiation therapy and chemotherapy (46 patients). Five years after the entry of the last patient and with a median follow-up of all survivors for 80 months, the recurrence rate was highest among the control patients (55 per cent) and lowest among the patients receiving a combination of adjuvant radiation and chemotherapy (33 per cent). Time to tumor recurrence differed significantly among the four treatment groups (P less than 0.04); it was significantly prolonged by combined radiation and chemotherapy as compared with resection alone (P less than 0.009). Overall survival did not differ significantly among the treatment groups. The superiority of the combined-modality regimen appeared to be attributable to the effects of radiation therapy and chemotherapy in controlling local and distant recurrences, respectively. We conclude that this study provides evidence supporting the use of postoperative radiation therapy in conjunction with chemotherapy in patients who have had "curative" resection of rectal cancer with involvement of perirectal fat or regional nodes or both (Stages B2 and C).
This article has been cited by other articles:
Carlomagno, C., Farella, A., Bucci, L., D'Armiento, F. P., Pesce, G., Pepe, S., Cannella, L., Pacelli, R., De Stefano, A., Solla, R., D'Armiento, M. R., De Placido, S.
(2009). Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol
20: 906-912
[Abstract][Full Text]
Castaldo, E. T., Parikh, A. A., Pinson, C. W., Feurer, I. D., Merchant, N. B.
(2009). Improvement of Survival With Response to Neoadjuvant Radiation Therapy for Rectal Cancer. Arch Surg
144: 129-134
[Abstract][Full Text]
Braendengen, M., Tveit, K. M., Berglund, A., Birkemeyer, E., Frykholm, G., Pahlman, L., Wiig, J. N., Bystrom, P., Bujko, K., Glimelius, B.
(2008). Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. JCO
26: 3687-3694
[Abstract][Full Text]
Casado, E., Pfeiffer, P., Feliu, J., Gonzalez-Baron, M., Vestermark, L., Jensen, H. A.
(2008). UFT (tegafur-uracil) in rectal cancer. Ann Oncol
19: 1371-1378
[Abstract][Full Text]
Harrison, J. D., Solomon, M. J., Young, J. M., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S.
(2008). Patient and Physician Preferences for Surgical and Adjuvant Treatment Options for Rectal Cancer. Arch Surg
143: 389-394
[Abstract][Full Text]
Kachnic, L. A., Hong, T. S., Ryan, D. P.
(2008). Rectal Cancer at the Crossroads: The Dilemma of Clinically Staged T3, N0, M0 Disease. JCO
26: 350-351
[Full Text]
Willett, C. G., Czito, B. G., Bendell, J. C.
(2007). Radiation Therapy in Stage II and III Rectal Cancer. Clin. Cancer Res.
13: 6903s-6908s
[Abstract][Full Text]
Aschele, C., Lonardi, S.
(2007). Multidisciplinary treatment of rectal cancer: medical oncology.. Ann Oncol
18: 1908-1915
[Full Text]
Czito, B. G., Willett, C. G.
(2007). Commentary: Rectal Cancer An Evolution of Treatment. The Oncologist
12: 1319-1320
[Full Text]
O'Dwyer, P. J., Eckhardt, S. G., Haller, D. G., Tepper, J., Ahnen, D., Hamilton, S., Benson, A. B. III, Rothenberg, M., Petrelli, N., Lenz, H.-J., Diasio, R., DuBois, R., Sargent, D., Sloan, J., Johnson, C. D., Comis, R. L., O'Connell, M. J.
(2007). Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. JCO
25: 2313-2321
[Abstract][Full Text]
Wolpin, B. M., Meyerhardt, J. A., Mamon, H. J., Mayer, R. J.
(2007). Adjuvant Treatment of Colorectal Cancer. CA Cancer J Clin
57: 168-185
[Abstract][Full Text]
Rodel, C., Liersch, T., Hermann, R. M., Arnold, D., Reese, T., Hipp, M., Furst, A., Schwella, N., Bieker, M., Hellmich, G., Ewald, H., Haier, J., Lordick, F., Flentje, M., Sulberg, H., Hohenberger, W., Sauer, R.
(2007). Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer. JCO
25: 110-117
[Abstract][Full Text]
Gill, S., Blackstock, A. W., Goldberg, R. M.
(2007). Colorectal Cancer. Mayo Clin Proc.
82: 114-129
[Abstract][Full Text]
Han, N., Galandiuk, S.
(2006). Induction Chemoradiation for Rectal Cancer. Arch Surg
141: 1246-1252
[Abstract][Full Text]
Nissan, A., Stojadinovic, A., Shia, J., Hoos, A., Guillem, J. G., Klimstra, D., Cohen, A. M., Minsky, B. D., Paty, P. B., Wong, W. D.
(2006). Predictors of Recurrence in Patients With T2 and Early T3, N0 Adenocarcinoma of the Rectum Treated by Surgery Alone. JCO
24: 4078-4084
[Abstract][Full Text]
Smalley, S. R., Benedetti, J. K., Williamson, S. K., Robertson, J. M., Estes, N. C., Maher, T., Fisher, B., Rich, T. A., Martenson, J. A., Kugler, J. W., Benson, A. B. III, Haller, D. G., Mayer, R. J., Atkins, J. N., Cripps, C., Pedersen, J., Periman, P. O., Tanaka, M. S. Jr, Leichman, C. G., Macdonald, J. S.
(2006). Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144. JCO
24: 3542-3547
[Abstract][Full Text]
Czito, B. G., Willett, C. G., Bendell, J. C., Morse, M. A., Tyler, D. S., Fernando, N. H., Mantyh, C. R., Blobe, G. C., Honeycutt, W., Yu, D., Clary, B. M., Pappas, T. N., Ludwig, K. A., Hurwitz, H. I.
(2006). Increased Toxicity With Gefitinib, Capecitabine, and Radiation Therapy in Pancreatic and Rectal Cancer: Phase I Trial Results. JCO
24: 656-662
[Abstract][Full Text]
Kalff, V., Duong, C., Drummond, E. G., Matthews, J. P., Hicks, R. J.
(2006). Findings on 18F-FDG PET Scans After Neoadjuvant Chemoradiation Provides Prognostic Stratification in Patients with Locally Advanced Rectal Carcinoma Subsequently Treated by Radical Surgery. JNM
47: 14-22
[Abstract][Full Text]
Rodel, C., Martus, P., Papadoupolos, T., Fuzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., Wittekind, C.
(2005). Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer. JCO
23: 8688-8696
[Abstract][Full Text]
Chau, I., Norman, A. R., Cunningham, D., Tait, D., Ross, P. J., Iveson, T., Hill, M., Hickish, T., Lofts, F., Jodrell, D., Webb, A., Oates, J. R.
(2005). A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol
16: 549-557
[Abstract][Full Text]
Hofheinz, R.-D., von Gerstenberg-Helldorf, B., Wenz, F., Gnad, U., Kraus-Tiefenbacher, U., Muldner, A., Hehlmann, R., Post, S., Hochhaus, A., Willeke, F.
(2005). Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer. JCO
23: 1350-1357
[Abstract][Full Text]
Sauer, R., Becker, H., Hohenberger, W., Rodel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., Karstens, J.-H., Liersch, T., Schmidberger, H., Raab, R., the German Rectal Cancer Study Group,
(2004). Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. NEJM
351: 1731-1740
[Abstract][Full Text]
Martenson, J. A. Jr, Willett, C. G., Sargent, D. J., Mailliard, J. A., Donohue, J. H., Gunderson, L. L., Thomas, C. R. Jr, Fisher, B., Benson, A. B. III, Myerson, R., Goldberg, R. M.
(2004). Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared With Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130. JCO
22: 3277-3283
[Abstract][Full Text]
Rich, T. A., Shepard, R. C., Mosley, S. T.
(2004). Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy. JCO
22: 2214-2232
[Abstract][Full Text]
Gunderson, L. L., Sargent, D. J., Tepper, J. E., Wolmark, N., O'Connell, M. J., Begovic, M., Allmer, C., Colangelo, L., Smalley, S. R., Haller, D. G., Martenson, J. A., Mayer, R. J., Rich, T. A., Ajani, J. A., MacDonald, J. S., Willett, C. G., Goldberg, R. M.
(2004). Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis. JCO
22: 1785-1796
[Abstract][Full Text]
Telford, J. J., Saltzman, J. R., Kuntz, K. M., Syngal, S.
(2004). Impact of Preoperative Staging and Chemoradiation Versus Postoperative Chemoradiation on Outcome in Patients With Rectal Cancer: A Decision Analysis. JNCI J Natl Cancer Inst
96: 191-201
[Abstract][Full Text]
Agulnik, M., Mullane, M. R.
(2003). Integrative Tumor Board: Colon Cancer with Liver Metastases. Integr Cancer Ther
2: 168-170
Hodgson, D. C., Zhang, W., Zaslavsky, A. M., Fuchs, C. S., Wright, W. E., Ayanian, J. Z.
(2003). Relation of Hospital Volume to Colostomy Rates and Survival for Patients With Rectal Cancer. JNCI J Natl Cancer Inst
95: 708-716
[Abstract][Full Text]
Cserni, G
(2003). Nodal staging of colorectal carcinomas and sentinel nodes. J. Clin. Pathol.
56: 327-335
[Abstract][Full Text]
Gennatas, C., Dardoufas, C., Mouratidou, D., Tsavaris, N., Pouli, A., Androulakis, G., Philippakis, M., Voros, D., Batalis, T., Besbeas, S., Hatzistylianos, G., Katsos, J., Komporozos, V., Legakis, N., Mallas, H., Peros, G., Photopoulos, A., Pisiotis, C., Polymeneas, G., Retalis, G., Samanidis, L., Smyrniotis, V., Stamatiadis, A., Vasiliou, J., Andreadis, H., Papadimitriou, J.
(2003). Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-{alpha}2b. Ann Oncol
14: 378-382
[Abstract][Full Text]
Glimelius, B.
(2002). Radiotherapy in rectal cancer. Br Med Bull
64: 141-157
[Abstract][Full Text]
Dunst, J., Reese, T., Sutter, T., Zuhlke, H., Hinke, A., Kolling-Schlebusch, K., Frings, S.
(2002). Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal Cancer. JCO
20: 3983-3991
[Abstract][Full Text]
Neugut, A. I., Fleischauer, A. T., Sundararajan, V., Mitra, N., Heitjan, D. F., Jacobson, J. S., Grann, V. R.
(2002). Use of Adjuvant Chemotherapy and Radiation Therapy for Rectal Cancer Among the Elderly: A Population-Based Study. JCO
20: 2643-2650
[Abstract][Full Text]
Tepper, J.E., O'Connell, M., Niedzwiecki, D., Hollis, D.R., Benson, A.B. III, Cummings, B., Gunderson, L.L., Macdonald, J.S., Martenson, J.A., Mayer, R.J.
(2002). Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex, and Local Control--Final Report of Intergroup 0114. JCO
20: 1744-1750
[Abstract][Full Text]
Lee, J.-H., Lee, J.-H., Ahn, J.-H., Bahng, H., Kim, T.-W., Kang, Y.-K., Lee, K.-H., Kim, J.-C., Yu, C.-S., Kim, J.-H., Ahn, S.-D., Kim, W.-K., Kim, S.-H., Lee, J.-S.
(2002). Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report. JCO
20: 1751-1758
[Abstract][Full Text]
Marijnen, C. A.M., Kapiteijn, E., van de Velde, C. J.H., Martijn, H., Steup, W. H., Wiggers, T., Kranenbarg, E. K., Leer, J. W.H.
(2002). Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial. JCO
20: 817-825
[Abstract][Full Text]
Tompkins, R. K., Ko, C. Y., Donovan, A. J.
(2001). Internationalization of General Surgical Journals: Origin and Content of Articles Published in North America and Great Britain From 1983 to 1998. Arch Surg
136: 1345-1351
[Abstract][Full Text]
Schrag, D., Gelfand, S. E., Bach, P. B., Guillem, J., Minsky, B. D., Begg, C. B.
(2001). Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results-Medicare. JCO
19: 3712-3718
[Abstract][Full Text]
Glynne-Jones, R., Debus, J.
(2001). Improving Chemoradiotherapy in Rectal Cancer. The Oncologist
6: 29-34
[Abstract][Full Text]
Marijnen, C.A.M., Nagtegaal, I.D., Kranenbarg, E. K., Hermans, J., van de Velde, C.J.H., Leer, J.W.H., van Krieken, J.H.J.M.
(2001). No Downstaging After Short-Term Preoperative Radiotherapy in Rectal Cancer Patients. JCO
19: 1976-1984
[Abstract][Full Text]
Hoff, P. M., Janjan, N., Saad, E. D., Skibber, J., Crane, C., Lassere, Y., Cleary, K. R., Benner, S., Randolph, J., Abbruzzese, J. L., Pazdur, R.
(2000). Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer. JCO
18: 3529-3534
[Abstract][Full Text]
Edler, D., Hallström, M., Johnston, P. G., Magnusson, I., Ragnhammar, P., Blomgren, H.
(2000). Thymidylate Synthase Expression: An Independent Prognostic Factor for Local Recurrence, Distant Metastasis, Disease-free and Overall Survival in Rectal Cancer. Clin. Cancer Res.
6: 1378-1384
[Abstract][Full Text]
Wolmark, N., Wieand, H. S., Hyams, D. M., Colangelo, L., Dimitrov, N. V., Romond, E. H., Wexler, M., Prager, D., Cruz, A. B. Jr., Gordon, P. H., Petrelli, N. J., Deutsch, M., Mamounas, E., Wickerham, D. L., Fisher, E. R., Rockette, H., Fisher, B.
(2000). Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. JNCI J Natl Cancer Inst
92: 388-396
[Abstract][Full Text]
TORTOLANI, P. J., KAUFMAN, H. S., NAHABEDIAN, M. Y., FRASSICA, F. J.
(1999). Pericapsular Fistula of the Hip After Radiation Therapy and Resection of a Rectal Carcinoma. A Case Report. JBJS
81: 1596-9
[Full Text]
Varma, M. G., Rogers, S. J., Schrock, T. R., Welton, M. L.
(1999). Local Excision of Rectal Carcinoma. Arch Surg
134: 863-868
[Abstract][Full Text]
Cannistra, S. A.
(1999). Back to the Future: Multiagent Chemotherapy in Ovarian Cancer Revisited. JCO
17: 741-741
[Full Text]
Swedish Rectal Cancer Trial,
(1997). Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer. NEJM
336: 980-987
[Abstract][Full Text]
Stryker, S. J., Kiel, K. D., Rademaker, A., Shaw, J. M., Ujiki, G. T., Poticha, S. M.
(1996). Preoperative 'Chemoradiation' for Stages II and III Rectal Carcinoma. Arch Surg
131: 514-519
[Abstract]
Saltz, L. B., Kemeny, N. E.
(1996). Adjuvant Chemotherapy of Colorectal Cancer. The Oncologist
1: 22-29
[Abstract][Full Text]
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., Rich, T. A.
(1994). Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery. NEJM
331: 502-507
[Abstract][Full Text]
Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., Hamilton, S. R.
(1994). Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer. NEJM
331: 213-221
[Abstract][Full Text]
Moertel, C. G.
(1994). Chemotherapy for Colorectal Cancer. NEJM
330: 1136-1142
[Full Text]
Welch, J. P., Welch, C. E.
(1993). Cancer of the Rectum: Where Are We? Where Are We Going?. Arch Surg
128: 697-702
[Abstract]
Marks, G., Mohiuddin, M., Eitan, A., Masoni, L., Rakinic, J.
(1991). High-Dose Preoperative Radiation and Radical Sphincter-Preserving Surgery for Rectal Cancer. Arch Surg
126: 1534-1540
[Abstract]
Daneker, G. W. Jr, Carlson, G. W., Hohn, D. C., Lynch, P., Roubein, L., Levin, B.
(1991). Endoscopic Laser Recanalization Is Effective for Prevention and Treatment of Obstruction in Sigmoid and Rectal Cancer. Arch Surg
126: 1348-1352
[Abstract]
Giovanella, B., Stehlin, J., Wall, M., Wani, M., Nicholas, A., Liu, L., Silber, R, Potmesil, M
(1989). DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. Science
246: 1046-1048
[Abstract]
Twomey, P., Burchell, M., Strawn, D., Guernsey, J.
(1989). Local Control in Rectal Cancer: A Clinical Review and Meta-Analysis. Arch Surg
124: 1174-1179
[Abstract]
McGarrity, T. J., Long, P. A., Peiffer, L. P., Converse, J. O., Kreig, A. F.
(1989). Results of a Television-Advertised Public Screening Program for Colorectal Cancer. Arch Intern Med
149: 140-144
[Abstract]
SEYDEL, H. G.
(1988). Treatment of Rectal Carcinoma. Arch Surg
123: 122-122
[Abstract]
Wile, A., Smolin, M.
(1987). Hyperthermic Pelvic Isolation-Perfusion in the Treatment of Refractory Pelvic Cancer. Arch Surg
122: 1321-1325
[Abstract]
Pearlman, N. W., Donohue, R. E., Stiegmann, G. V., Ahnen, D. J., Sedlacek, S. M., Braun, T. J.
(1987). Pelvic and Sacropelvic Exenteration for Locally Advanced or Recurrent Anorectal Cancer. Arch Surg
122: 537-541
[Abstract]
Fortier, G. A., Constable, W. C., Meyers, H., Wanebo, H. J.
(1986). Preoperative Radiation Therapy for Rectal Cancer: An Effective Therapy in Need of a Clinical Trial. Arch Surg
121: 1380-1385
[Abstract]
Bradley, S. J., Garfinkle, G., Walker, E., Salem, R., Chen, L. B., Steele, G. Jr
(1986). Increased Expression of the Epidermal Growth Factor Receptor on Human Colon Carcinoma Cells. Arch Surg
121: 1242-1247
[Abstract]
Bleday, R., Weiss, M. J., Salem, R. R., Wilson, R. E., Chen, L. B., Steele, G. Jr
(1986). Inhibition of Rat Colon Tumor Isograft Growth With Dequalinium Chloride. Arch Surg
121: 1272-1275
[Abstract]
